Investment Strategies Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types November 19, 2024
Investment Strategies Resonance Contracted by Major Global Pharma Company for Clinical Drug Trial Worth $13.775 Million over 24 Months November 19, 2024
Investment Strategies Notice of Initial Substantial Holder – Regal Funds Management Pty Ltd November 18, 2024
Investment Strategies Top Stories This Week: Gold’s Post-Election Price Drop Explained, Friedland’s ASX Iron Ore IPO November 17, 2024
Investment Strategies Top 5 Canadian Mining Stocks This Week: Canterra Surges 150 Percent on High Grades from Surface November 16, 2024
Investment Strategies Exclusive Interview with Linius Technologies CEO James Brennan November 16, 2024
Investment Strategies Exclusive Interview with Forward Water Technologies CEO Howie Honeyman November 16, 2024